Weight Management for Type 2 Diabetes Mellitus: Global Cardiovascular Risk Reduction
- 19 February 2007
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 99 (4) , 68-79
- https://doi.org/10.1016/j.amjcard.2006.11.007
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetesInternational Journal of Obesity, 2006
- Obesity and Cardiovascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Prevalence of Overweight and Obesity in the United States, 1999-2004JAMA, 2006
- Epidemiology, Trends, and Morbidities of Obesity and the Metabolic SyndromeEndocrine, 2006
- Is visceral obesity the cause of the metabolic syndrome?Annals of Medicine, 2006
- Adiponectinemia in Visceral Obesity: Impact on Glucose Tolerance and Plasma Lipoprotein and Lipid Levels in MenJournal of Clinical Endocrinology & Metabolism, 2005
- Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001JAMA, 2003
- ObesityNew England Journal of Medicine, 2002
- Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and HyperinsulinemiaJournal of Clinical Endocrinology & Metabolism, 2001
- Plasminogen activator inhibitor activity in diabetic and nondiabetic survivors of myocardial infarction.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993